Related Experiment Videos
Prognostic value of the pressure-volume ratio in patients with coronary artery disease
Insights
The peak-systolic pressure/end-systolic volume ratio (PSP/ESV) predicts long-term survival in coronary artery disease patients. However, ejection fraction proved a more powerful predictor of outcomes in both surgical and medical treatments.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Internal Medicine
Background:
- Coronary artery disease (CAD) management involves surgical or medical interventions.
- Left ventricular (LV) function assessment is crucial for predicting patient outcomes.
- The PSP/ESV ratio is a load-insensitive index of LV function.
Purpose of the Study:
- To evaluate the PSP/ESV ratio's ability to predict perioperative mortality and long-term survival.
- To compare the predictive power of PSP/ESV ratio with ejection fraction in CAD patients.
Main Methods:
- Retrospective study of 4,829 patients with coronary artery disease.
- Calculation of cardiac volumes, ejection fraction, and PSP/ESV ratio.
- Long-term follow-up via annual questionnaires.
Main Results:
- PSP/ESV ratio did not significantly predict in-hospital mortality after coronary surgery.
- PSP/ESV ratio predicted long-term survival in both surgically and medically treated patients.
- Ejection fraction was a more significant predictor of survival than PSP/ESV ratio in both groups.
Conclusions:
- The PSP/ESV ratio is a valuable predictor of long-term survival in coronary artery disease.
- Ejection fraction demonstrates superior predictive capability for patient outcomes compared to PSP/ESV ratio.
- Findings support the use of PSP/ESV ratio in risk stratification for CAD patients.
Abstract:
To determine if the peak-systolic pressure/end-systolic volume ratio [PSP/ESV], a load-insensitive index of left ventricular function, predicted perioperative mortality and long-term survival after coronary artery bypass surgery or medical treatment, 4,829 patients with coronary artery disease were studied retrospectively. Cardiac volumes, ejection fraction, and PSP/ESV ratio were computed using standard methods, and follow-up was performed using annual questionnaires. PSP/ESV ratio values were not significantly different (p = .09) between those who died during hospitalization (n = 101) after coronary surgery and those who were discharged. Long-term follow-up in surgically treated patients demonstrated a 97% 3-year and 93% 5-year survival for those with PSP/ESV over 2.292. These were significantly greater (p = .0026) in value in patients with PSP/ESV less than 1.237 (3-year and 5-year survival of 92 and 79.2%, respectively). In the medical group, survival rate for those with PSP/ESV over 2.292 at 5 years was 89.3%, while for those with PSP/ESV less than 1.237 it was 52.5% (p less than .001). Multivariate analysis, however, showed ejection fraction to be a more significant predictor of survival in both the groups compared with PSP/ESV ratio. Thus, PSP/ESV ratio does predict long-term survival in coronary disease patients treated either surgically or medically. Ejection fraction was nevertheless a more powerful predictor of outcome.